Prime Therapeutics Is Acquiring Magellan Rx To Advance Integrated Specialty Drug Management, Accelerating Efforts To Lower The Cost Of Drugs And Improve Health Outcomes
Prime Therapeutics Is Acquiring Magellan Rx To Advance Integrated Specialty Drug Management, Accelerating Efforts To Lower The Cost Of Drugs And Improve Health Outcomes
05/05/22, 1:04 PM
Location
Industry
insurance
Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3 entered into a definitive agreement with Centene Corporation to acquire Magellan Health, Inc.'s pharmacy business, Magellan Rx Management, (Magellan Rx) for approximately $1.35 billion.
Company Info
Location
Eagan, Minnesota, United States
Company info
Everything we do is connected to helping people get the medicine they need to feel better and live well. It’s meaningful work and we’ve been doing it for over 24 years.
In the pharmacy benefit management (PBM) industry, we’re different. We’re owned by 18 not-for-profit Blue Cross and Blue Shield health plans. This allows us to control costs and empower our employees to put members first. It’s a successful combination. We have the lowest pharmacy trend in the industry and serve 28+ million members throughout the US.